Physiological and structural responses to chronic experimental renal allograft injury

1994 ◽  
Vol 267 (6) ◽  
pp. F1102-F1106 ◽  
Author(s):  
A. Junaid ◽  
S. M. Kren ◽  
M. E. Rosenberg ◽  
K. A. Nath ◽  
T. H. Hostetter

Chronic rejection necessitates a return to dialysis or retransplantation for a significant number of patients with renal allografts. Although alloresponses between donor organ and recipient importantly determine this process, the detailed immunologic processes and organ physiology of chronic rejection are unclear; in consequence its mechanism and therapy are uncertain. A model of chronic rejection in the rat was used to examine several facets of this process. Fisher-to-Lewis (F-L), allogeneic, and Lewis-to-Lewis (L-L), syngeneic, renal transplants were performed in nephrectomized recipients. All rats were treated with cyclosporin A (5 mg.kg-1.day-1) for 10 days from the time of grafting. At 6 wk, allogeneically grafted animals had a higher protein excretion rate (F-L, 47 +/- 30 mg/day; L-L, 17 +/- 6 mg/day; P <0.05) and an increase in glomerular capillary pressure (F-L, 69 +/- 5 mmHg; L-L, 58 +/- 8 mmHg; P <0.05) and fractional cortical interstitial volume (F-L, 29.8 +/- 4.3%; L-L, 19.5 +/- 4.0%; P < 0.01). This model of chronic rejection is characterized by glomerular capillary hypertension, proteinuria, and cortical interstitial expansion. Because these findings are also present in other models of chronic renal injury, mechanisms in addition to alloresponses may operate in chronic rejection.

2018 ◽  
Vol 9 ◽  
pp. 204173141877294 ◽  
Author(s):  
Pavan Kottamasu ◽  
Ira Herman

Donor organ shortage remains a clear problem for many end-stage organ patients around the world. The number of available donor organs pales in comparison with the number of patients in need of these organs. The field of tissue engineering proposes a plausible solution. Using stem cells, a patient’s autologous cells, or allografted cells to seed-engineered scaffolds, tissue-engineered constructs can effectively supplement the donor pool and bypass other problems that arise when using donor organs, such as who receives the organ first and whether donor organ rejection may occur. However, current research methods and technologies have been unable to successfully engineer and vascularize large volume tissue constructs. This review examines the current perfusion methods for ex vivo organ systems, defines the different types of vascularization in organs, explores various strategies to vascularize ex vivo organ systems, and discusses challenges and opportunities for the field of tissue engineering.


1992 ◽  
Vol 5 (2) ◽  
pp. 85-95 ◽  
Author(s):  
Serdar Yilmaz ◽  
Eero Taskinen ◽  
Timo Paavonen ◽  
Ari Mennander ◽  
Pekka Häyry

1997 ◽  
Vol 29 (1-2) ◽  
pp. 1522-1523 ◽  
Author(s):  
B. Kozfowska-Boszko ◽  
M. Lao ◽  
Z. Gaciong ◽  
J. Sicńska ◽  
M. Durlik ◽  
...  

1995 ◽  
Vol 59 (9) ◽  
pp. 1280-1284 ◽  
Author(s):  
JAN L.C.M. VAN SAASE ◽  
FOKKO J. VAN DER WOUDE ◽  
JANE THOROGOOD ◽  
ADRIANUS A.M.J. HOLLANDER ◽  
LEENDERT A. VAN ES ◽  
...  

2005 ◽  
Vol 19 (s14) ◽  
pp. 20-26 ◽  
Author(s):  
Kumi Aita ◽  
Yutaka Yamaguchi ◽  
Shigeru Horita ◽  
Mayuko Ohno ◽  
Kazunari Tanabe ◽  
...  

1992 ◽  
Vol 5 (2) ◽  
pp. 85-95 ◽  
Author(s):  
Serdar Yilmaz ◽  
Eero Taskinen ◽  
Timo Paavonen ◽  
Ari Mennander ◽  
Pekka H�yry

1996 ◽  
Vol 10 (6) ◽  
pp. 723-727 ◽  
Author(s):  
Claude Guyot ◽  
Jean-Michel Nguyen ◽  
Pierre Cochat ◽  
Michel Foulard ◽  
François Bouissou ◽  
...  

1996 ◽  
Vol 62 (11) ◽  
pp. 1571-1576 ◽  
Author(s):  
Fernando G. Cosio ◽  
Wenzi Qiu ◽  
Mitchell L. Henry ◽  
Michael E. Falkenhain ◽  
Elmahdi A. Elkhammas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document